Mitotane Capsule

Mitotane Capsules serve as a cornerstone adrenolytic therapy, meticulously designed to suppress adrenal cortex activity and modify peripheral steroid metabolism in the treatment of advanced adrenocortical carcinoma. The formulation achieves therapeutic synergy by combining direct cytotoxic effects on malignant cells with the systemic regulation of adrenal hormone production to manage the complex pathophysiology of the disease. This encapsulated delivery system provides critical clinical benefits, including precise dose titration and enhanced bioavailability, ensuring the maintenance of steady-state plasma concentrations while improving patient tolerance during long-term administration.